The Top 20 pharma companies in France, ranked by total turnover at ex-manufacturer prices for 2018. Swiss giant Novartis is in first place with a EUR 2.6 billion turnover, a full 89 percent of which came from the retail market. In second place is local champion Sanofi with a turnover of EUR 1.7 billion, followed by generics specialists Mylan with EUR 1.6 billion.
A snapshot of the latest data on the French pharmaceutical industry from industry association LEEM, including…
France spends 11.6% of its GDP on health. This is behind the USA (17.1%) but ahead of Germany (11.2%), Japan…
The Top 10 pharma companies in the EUR 28.9 million French pharma market in 2019. Homegrown players Sanofi and…
Top 20 Pharma Companies in France The following chart shows the top 20 pharma companies in France, ranked by sales…
This map shows the overall contribution of the pharmaceutical industry to the French economy, including number of…
The National Health Insurance Fund for employees (CNAMTS) is in charge of the health insurance branch of the Social…
The latest news from French pharma, including why President Emmanuel Macron’s initiative to bring medical…
While Big Pharma companies like Pfizer, Janssen and AstraZeneca, have grabbed the headlines over the past year for…
The latest from French pharma where Sanofi has inked a deal to produce 125 million doses of Pfizer’s COVID-19…